Cart
sales@molnova.com
D-Glucose 6-phosphate potassium salt
CAS No. 103192-55-8
D-Glucose 6-phosphate potassium salt( —— )
Catalog No. M19868 CAS No. 103192-55-8
In cells D-glucose 6-phosphate (G6P) is generated when glucose is phosphorylated by hexokinase or glucokinase or by the conversion of glucose-1-phosphate by phosphoglucomutase during glycogenolysis. G6P lies at the beginning of both glycolysis and the pentose phosphate pathways. It also can be stored as glycogen when blood glucose levels are high.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 31 | In Stock |
|
| 25MG | 48 | In Stock |
|
| 50MG | 66 | In Stock |
|
| 100MG | 91 | In Stock |
|
| 200MG | 152 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameD-Glucose 6-phosphate potassium salt
-
NoteResearch use only, not for human use.
-
Brief DescriptionIn cells D-glucose 6-phosphate (G6P) is generated when glucose is phosphorylated by hexokinase or glucokinase or by the conversion of glucose-1-phosphate by phosphoglucomutase during glycogenolysis. G6P lies at the beginning of both glycolysis and the pentose phosphate pathways. It also can be stored as glycogen when blood glucose levels are high.
-
DescriptionIn cells D-glucose 6-phosphate (G6P) is generated when glucose is phosphorylated by hexokinase or glucokinase or by the conversion of glucose-1-phosphate by phosphoglucomutase during glycogenolysis. G6P lies at the beginning of both glycolysis and the pentose phosphate pathways. It also can be stored as glycogen when blood glucose levels are high.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number103192-55-8
-
Formula Weight298.23
-
Molecular FormulaC6H12O9PK
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILES[K+].OC1O[C@H](COP(O)([O-])=O)[C@@H](O)[C@H](O)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cappellini M.D. and Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 371(9606) 64-74 (2008).
molnova catalog
related products
-
RNAIII-inhibiting pe...
RNAIII-inhibiting peptide(TFA) is a potent inhibitor of Staphylococcus aureus, effective in the diseases such as cellulitis, keratitis, septic arthritis, osteomylitis and mastitis.RNAIII-inhibiting peptide(TFA) is a potent inhibitor of Staphylococcus aureus.
-
Atractylenolide I
Atractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS.
-
L-DABA hydrobromide
L-DABA hydrobromide (L-2,4-Diaminobutyric acid hydrobromide) is a potent GABA transaminase inhibitor with antitumor and anticonvulsant activity for the study of neurological disorders.
